Fibrin gel induces the migration of smooth muscle cells from rabbit aortic explants

Thrombosis and Haemostasis

Volumn 82, Issue 4, 1999, Pages 1347-1352

  Nomura, Hideki ^a   Naito, Michitaka ^a   Iguchi, Akihisa ^a   Thompson, W Douglas ^b   Smith, Elspeth B ^b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Fibrin gel; Integrin (v) 3; Migration; Phenotype; Smooth muscle cell

Indexed keywords

ACTIN; FIBRIN; FIBRINOGEN; GROWTH FACTOR; HIRUDIN; INTEGRIN; MYOSIN HEAVY CHAIN; THROMBIN; THROMBIN INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; CELL MIGRATION; EXPLANT; IMMUNOHISTOCHEMISTRY; INTIMA; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE FIBER;

EID: 0032881043     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614388     Document Type: Article

References (31)

1. Smith EB, Slater RS, Hunter JA. Quantitative studies on fibrinogen and low density lipoprotein in human aortic intima. Atherosclerosis 1973; 18: 479-87.
2. Smith EB, Thompson WD. Fibrin as a factor in atherogenesis. Thromb Res 1994; 73: 1-19.
3. Shekhonin BV, Tararak EM, Samokhin GP, Mitkevich OV, Mazurov AV, Vinogradov DV, Vlasik TN, Kalantarov GF, Koteliansky VE. Visualization of apo B, fibrinogen/fibrin, and fibronectin in the intima of normal human aorta and large arteries and during atherosclerosis. Atherosclerosis 1990; 213-26.
4. Naito M, Hayashi T, Iguchi A, New approaches to the prevention of atherosclerosis. Drugs 1995; 50: 440-53.
5. Bini A, Fenoglio JJ, Sobel J, Owen J, Fejgi M, Kaplan KL. Immunochemical characterization of fibrinogen, fibrin I and fibrin II in human thrombi and atherosclerotic lesions. Blood 1987; 69: 1038-45.
6. Bini A, Fenoglio JJ, Mesa-Tejada R, Kudryk B, Kaplan KL. Identification and distribution of fibrinogen, fibrin and fibrin(ogen) degradation products in atherosclerosis. Arteriosclerosis 1989; 9: 109-21.
7. Smith EB, Keen GA, Grant A, Stirk C. Fate of fibrinogen in human arterial intima. Arteriosclerosis 1990; 10: 263-75.
8. Smith EB, Alexander KM, Massie IB. Insoluble "fibrin" in human aortic intima. Quantitative studies on the relationship between insoluble "fibrin", soluble fibrinogen and low density lipoprotein. Atherosclerosis 1976; 23: 19-39.
9. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-9.
10. Naito M, Hayashi T, Kuzuya M, Funaki C, Asai K, Kuzuya F. Fibrinogen is chemotactic for vascular smooth muscle cells. FEBS Lett 1989; 247: 358-60.
11. Naito M, Hayashi T, Kuzuya M, Funaki C, Asai K, Kuzuya F. Effects of fibrinogen and fibrin on the migration of vascular smooth muscle cells in vitro. Atherosclerosis 1990; 83: 9-14.
12. Naito M, Funaki C, Hayashi T, Yamada K, Asai K, Yoshimine N. Kuzuya F. Substrate-bound fibrinogen, fibrin and other cell attachment-promoting proteins as a scaffold for cultured vascular smooth muscle cells. Atherosclerosis 1992; 96: 227-34.
13. Naito M, Nomura H, Iguchi A. Migration of cultured vascular smooth muscle cells into non-crosslinked fibrin gels. Thromb Res 1996; 84: 129-36.
14. Naito M, Nomura H, Iguchi A, Thompson WD, Smith EB. Effect of cross-linking by factor XIIIa on the migration of vascular smooth muscle cells into fibrin gels. Thromb Res 1998; 90: 111-6.
15. Chamley-Campbell J, Campbell GR, Ross R. The smooth muscle cell in culture. Physiol Rev 1979; 59: 1-61.
16. Thyberg J, Hedin U, Sjolund M, Palmberg L. Bottger BA. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis 1990; 10: 966-90.
17. Rekhter MD, Andreeva AA, Mironov AA, Orekov AN. Three-dimensional cytoarchitecture of normal and atherosclerotic intima of human aorta. Am J Pathol 1991; 138: 569-80.
18. Kuro-o M, Nagai R, Nakahara K, Katoh H, Tsai RC, Tsuchimochi H, Yazaki Y, Ohkubo A, Takaku F. cDNA cloning of a myosin heavy chain isoform in embryonic smooth muscle and its expression during vascular development and in arteriosclerosis. J Biol Chem 1991; 266: 3768-73.
19. Thompson WD, Smith EB, Stirk CM, Marshall FI, Stout AJ, Kocchar A. Angiogenic activity of fibrin degradation products is located in fibrin fragment E. J Pathol 1992; 168: 47-53.
20. Stirk CM, Kocchar A, Smith EB, Thompson WD. Presence of growth-stimulating fibrin degradation products containing fragment E in human atherosclerotic plaques. Atherosclerosis 1993; 103: 159-69.
21. Naito M, Sabally K, Thompson WD, Stirk CM, Smith EB, Benjamin N. Stimulation of proliferation of smooth muscle cells in culture by fibrin degradation products. Fibrinolysis 1996; 10 (Suppl 4): 12.
22. Freedman JE, Fabian A, Loscalzo J. Impaired EDRF production by endothelial cells exposed to fibrin monomer and FDP. Am J Physiol 1995; 268: C520-6.
23. Ge M, Ryan TJ, Lum H, Malik AB. Fibrinogen degradation product fragment D increases endothelial monolayer permeability. Am J Physiol 1991; 261: L283-9.
24. Scrutton MC, Rossmurphy SB, Bennett GM et al. Changes in clot deformability - a possible explanation for the epidemiological association between plasma fibrinogen concentration and myocardial infarction. Blood Coag Fibrinol 1994; 5: 719-23.
25. Fatah K, Beving H, Albage A, Ivert T, Blomback M. Acetylsalicylic acid may protect the patient by increasing fibrin gel porosity. Is withdrawing of treatment harmful to the patient? Eur Heart J 1996; 17: 1362-6.
26. Naito M, Hayashi T, Kuzuya M, Funaki C, Asai K, Kuzuya F. Thrombin stimulates the migration of fetal bovine aortic smooth muscle cells in culture, Igakunoayumi 1988; 144: 699-700. (In Japanese, Abstract in English)
27. Farrell DH, Al-Mondhiry A. Human fibroblast adhesion to fibrinogen. Biochemistry 1997; 36: 1123-8.
28. vβ3. Exp Cell Res 1997; 232: 118-26.
29. 3 integrin in mediating fibrin gel retraction. J Biol Chem 1995; 270: 1785-90.
30. 3. Blood 1995; 86: 2606-15.
31. 3 integrin expression in normal and atherosclerotic artery. Circ Res 1995; 77: 1129-35.